AM-Pharma's Phase II sepsis readout triggers Pfizer's takeout option

By Elizabeth S. Eaton | Mar 9, 2018 | 9:38 PM GMT

AM-Pharma B.V. (Bunnik, the Netherlands) reported mixed data on Friday from the Phase II STOP-AKI trial of recAP to treat